Skip to Main content Skip to Navigation
Journal articles

Protocol Biopsies in Patients with Subclinical De Novo DSA After Kidney Transplantation

Abstract : BACKGROUND: De novo donor-specific antibodies (DSA) are associated with antibody-mediated rejection (AMR) and allograft loss. Whether monitoring of de novo DSA (dnDSA) paired with systematic kidney biopsy should become routine remains to be established. METHODS: A retrospective multicentric study (9 French kidney transplant units of the Spiesser Group) included patients without graft dysfunction biopsied because of the presence of de novo DSA (One Lambda, MFI > 1000). RESULTS: 123 patients (85M/38F; mean age: 49.5 ± 13.1 years old) were biopsied after the detection of a dn DSA, 65.3 months (median) after kidney transplantation. Graft function was stable within 3 months before biopsy (estimated glomerular filtration rate (eGFR): 55.3 ± 18.9 ml/min/1.73m²). Fifty-one subclinical AMR (sAMR) (41.4%) were diagnosed, of which 32 (26%) active and 19 (15.5%) chronic active sAMR. Seventy-two biopsies revealed no AMR (58.5%). Predictive factors associated with the diagnosis of active sAMR were MFI of immunodominant DSA > 4000, MFI of the sum of DSA > 6300, age of the recipient < 45 y, and the absence of steroids at biopsy. The presence of proteinuria > 200 mg/g was predictive of chronic active sAMR. The decrease of eGFR at 5 years post biopsy was significantly higher in patients with acute sAMR (-25.2 ± 28.3 mL/min/1.73m²) and graft survival significantly lower. CONCLUSION: Performing a kidney graft biopsy for the occurrence of dnDSA without renal dysfunction leads to the diagnosis of a sAMR in over 40% of cases. Neverthess, we did not observe any effect of standard treatment in acute sAMR.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-02444985
Contributor : Dominique Guerrot <>
Submitted on : Sunday, January 19, 2020 - 6:27:29 PM
Last modification on : Thursday, May 27, 2021 - 12:27:22 PM

Links full text

Identifiers

Citation

Dominique Bertrand, Philippe Gatault, Maite Jaureguy, Cyril Garrouste, Johnny Sayegh, et al.. Protocol Biopsies in Patients with Subclinical De Novo DSA After Kidney Transplantation. Transplantation, Lippincott, Williams & Wilkins, 2019, ⟨10.1097/TP.0000000000003055⟩. ⟨inserm-02444985⟩

Share

Metrics

Record views

102